Response Oncology (Response Oncology) EV-to-EBITDA : 0.00 (As of Apr. 25, 2024)

Response Oncology EV-to-EBITDA Chart

Response Oncology Annual Data
	Trend	Dec92	Dec93	Dec94	Dec95	Dec96	Dec97	Dec98	Dec99	Dec00	Dec01
EV-to-EBITDA		Get a 7-Day Free Trial					9.40	8.14	6.81	-2.50	0.14

Response Oncology Quarterly Data
	Jun97	Sep97	Dec97	Mar98	Jun98	Sep98	Dec98	Mar99	Jun99	Sep99	Dec99	Mar00	Jun00	Sep00	Dec00	Mar01	Jun01	Sep01	Dec01	Mar02
EV-to-EBITDA	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Response Oncology's EV-to-EBITDA

For the Medical Care Facilities subindustry, Response Oncology's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Response Oncology's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Response Oncology's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Response Oncology's EV-to-EBITDA falls into.

Response Oncology EV-to-EBITDA Calculation

Response Oncology's EV-to-EBITDA for today is calculated as:

Response Oncology's current Enterprise Value is $0.0 Mil.
Response Oncology's EBITDA for the trailing twelve months (TTM) ended in Mar. 2002 adds up the quarterly data reported by the company within the most recent 12 months, which was $-48.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Response Oncology  (GREY:ROIX) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Response Oncology's PE Ratio for today is calculated as:

Response Oncology's share price for today is $0.0001.
Response Oncology's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2002 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.150.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Response Oncology EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Response Oncology's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Response Oncology (Response Oncology) Business Description